Home > Press > Production of Non-Virus Nanocarriers with Highest Amount of Gene Delivery
Abstract:
Iranian researchers from Tarbiat Modarres University changed the liposome production process and increased the amount of genes entrapped in the structure of these nanocarriers.
The non-virus nanocarriers have neutral structure and very high stability and they protect entrapped genes against degrading enzymes.
In this research, some changes were made in the synthesis of liposomes and nanocarriers were produced that can entrap DNA molecules with very high efficiency (98%) in their absolutely neutral structure. The results have so far been reported only for cationic liposomes that are highly toxic and can only be used in-vivo.
The nanostructure is very stable, to the extent that no release of DNA has been observed from it after six months. DNA is trapped in aqueous environment inside the liposome. Therefore, degrading enzymes are not able to degrade DNA molecule, and as a result, DNA has very high stability inside the structure.
Among other advantages of the designed nanocarrier, mention can be made of its very high ability in gene delivery to bacterium cell. Therefore, it can be used in the treatment of infections caused by bacteria, which are resistant to medications. The nanostructure can also be used as an appropriate carrier to delivery medications in the treatment of human diseases. The research team is currently carrying out studies on gene delivery to bacterium cells through this system.
Taking into account the obtained results, the researchers are hopeful that liposomes derived from cellular membrane will have important role in drug and gene delivery in the near future; therefore, they will take the place of toxic cationic carriers that are currently used.
Results of the research have been published in Molecular Biotechnology, vol. 55, issue 2, October 2013, pp. 120-130.
####
For more information, please click here
Copyright © Fars News Agency
If you have a comment, please Contact us.Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
Related News Press |
News and information
Beyond wires: Bubble technology powers next-generation electronics:New laser-based bubble printing technique creates ultra-flexible liquid metal circuits November 8th, 2024
Nanoparticle bursts over the Amazon rainforest: Rainfall induces bursts of natural nanoparticles that can form clouds and further precipitation over the Amazon rainforest November 8th, 2024
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Nanomedicine
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Unveiling the power of hot carriers in plasmonic nanostructures August 16th, 2024
Discoveries
Breaking carbon–hydrogen bonds to make complex molecules November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Turning up the signal November 8th, 2024
Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024
Announcements
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Turning up the signal November 8th, 2024
Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024
Interviews/Book Reviews/Essays/Reports/Podcasts/Journals/White papers/Posters
Beyond wires: Bubble technology powers next-generation electronics:New laser-based bubble printing technique creates ultra-flexible liquid metal circuits November 8th, 2024
Nanoparticle bursts over the Amazon rainforest: Rainfall induces bursts of natural nanoparticles that can form clouds and further precipitation over the Amazon rainforest November 8th, 2024
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Nanobiotechnology
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
The mechanism of a novel circular RNA circZFR that promotes colorectal cancer progression July 5th, 2024
The latest news from around the world, FREE | ||
Premium Products | ||
Only the news you want to read!
Learn More |
||
Full-service, expert consulting
Learn More |
||